NextPlat to Release Third Quarter 2026 Results on Thursday, November 12, 2026
Investor Conference Call Scheduled for Thursday, November 12, 2026 at 8:30 a.m. EasternHALLANDALE BEACH, Fla., Nov. 6, 2026 /PRNewswire/ --...
Investor Conference Call Scheduled for Thursday, November 12, 2026 at 8:30 a.m. EasternHALLANDALE BEACH, Fla., Nov. 6, 2026 /PRNewswire/ --...
North Texas Plastic Surgery founder receives peer-nominated recognition in the Southlake publication's feature for top doctors SOUTHLAKE, TX / ACCESS...
Company Highlights CD228V as its Principal Development Priority, Proposed SPAC Business Combination at ~ $135 Million Valuation for SkinJect® and...
SAN FRANCISCO, CA / ACCESS Newswire / November 6, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today...
WOOSTER, Ohio and NEW ORLEANS, Nov. 6, 2026 /PRNewswire/ -- For people living with ALS, maintaining communication can mean preserving...
Study demonstrated no dose-limiting toxicities and dose-responsive cytokine production consistent with TLR7/8 engagementResults support continued clinical development of INI-4001 as...
ROCHESTER, N.Y., Nov. 6, 2026 /PRNewswire/ -- AeroSafe Global, a pioneer in Cold-Chain-as-a-Service (CCaaS) for the pharmaceutical industry, is proud...
Experienced healthcare technology and operations executive to lead FinThrive's next chapter of innovation, operational excellence and growthCEO Hemant Goel to...
Langlotz will advise on how AI-assisted radiology reporting is validated and built around radiologists; Raidium to host November 10 webinar...
Statewide digital infrastructure will connect correctional facilities, field staff, and community partners across all four counties to streamline care delivery,...
New Category Will Introduce a Closed-Loop Framework: Predict. Perform. Recover. Keeping the Surgeon's Expertise and Control at the Center of...
Discussions will highlight progress from CREATE's four clinical-stage in vivo CAR programs across autoimmune disease and oncologyCAMBRIDGE, Mass., Nov. 6,...
Experienced osteopathic association executive to succeed Bob Moore in January 2027 CHICAGO, IL / ACCESS Newswire / November 6, 2026...
INTASYL siRNA - Redefining the Treatment Paradigm for Cutaneous Squamous Cell CarcinomaKing of Prussia, Pennsylvania--(Newsfile Corp. - November 6, 2026)...
- Adoption of Advance Notice Policy -- Appointment of LifeSci Advisors - Vancouver, British Columbia--(Newsfile Corp. - November 6, 2026)...
Kos joins Sutter Hill Ventures and other leading investors in backing Fathom Therapeutics's pioneering physics- and AI-powered drug discovery platformNEW...
Reports third quarter revenue of $1.3 billion, GAAP net income of $0.2 billion and GAAP diluted EPS of $0.38Increases 2026...
Advances PBH Development Program Following August 2026 Initial Public OfferingStrengthens Balance Sheet with $82.1 Million in Total Cash, Cash Equivalents,...
Agreement adds $250,000 in research funding and a master distributor relationship to support product development and commercialization across Vitalcore, Best365Labs...
Vamorolone is one of five treatments selected for the rare disease reimbursement pilot program.The program aims to shorten the National...